DashboardPortfoliosFavoritenGemeinschaftEntdeckenSuchen
NOT FOR DISTRIBUTION
Loading...
  • Bestände
  • /
  • Gesundheitswesen
Vor 1Tg aktualisiert
VIMIAN logo

Vimian Group AB (publ)OM:VIMIAN Aktienübersicht

Marktkapitalisierung SEK 18.3b
Vor 1Tg aktualisiert
Aktienkurs
n/a
1Y14.5%
7D0.6%
1D0.6%
Wert des Portfolios
​
Siehe

Vimian Group AB (publ)

OM:VIMIAN Lagerbericht

Marktkapitalisierung: SEK 18.3b

  • Unternehmensüberblick
    • Bewertung
    • Ausblick und Wachstum
    • Leistungs-Rückblick
    • Finanzlage
    • Dividende
  • Management
  • Eigentümerschaft
  • Weitere Informationen
  • Aktien-Community

Vimian Group (VIMIAN) Aktienübersicht

Vimian Group AB (publ) ist weltweit im Bereich der Tiergesundheit tätig. Mehr Details

VIMIAN grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung3/6
Künftiges Wachstum4/6
Vergangene Leistung5/6
Finanzielle Gesundheit4/6
Dividenden0/6

Belohnungen

31.2% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes Gewinnwachstum 30.06% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 61.4%

Risikoanalyse

Bei unseren Risikoprüfungen wurden keine Risiken für VIMIAN festgestellt.

VIMIAN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
7.0% unterbewertet intrinsischer Abschlag
AnalystConsensusTarget
•2d ago

Digital Adoption And Niche Expansion Will Empower Veterinary Healthcare

102
0
2
AN
AnalystHighTarget
15.8% unterbewertet intrinsischer Abschlag
AnalystHighTarget
•3mo ago

Emerging Pet Trends And Digital Diagnostics Will Redefine Animal Healthcare

30
0
0
AN
AnalystLowTarget
18.8% überbewertet intrinsischer Abschlag
AnalystLowTarget
•1mo ago

Rising Interest Rates And Tariffs Will Weaken US MedTech Margins

24
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
7.0% unterbewertet intrinsischer Abschlag
AnalystConsensusTarget
•2d ago

Digital Adoption And Niche Expansion Will Empower Veterinary Healthcare

102
0
2
AN
AnalystHighTarget
15.8% unterbewertet intrinsischer Abschlag
AnalystHighTarget
•3mo ago

Emerging Pet Trends And Digital Diagnostics Will Redefine Animal Healthcare

30
0
0
AN
AnalystLowTarget
18.8% überbewertet intrinsischer Abschlag
AnalystLowTarget
•1mo ago

Rising Interest Rates And Tariffs Will Weaken US MedTech Margins

24
0
0
View all narratives

Vimian Group AB (publ) Wettbewerber

Xvivo Perfusion

Symbol: OM:XVIVO
Market cap: SEK 7.8b

Bio-Works Technologies

Symbol: NGM:BIOWKS
Market cap: SEK 330.0m

MedCap

Symbol: OM:MCAP
Market cap: SEK 7.9b

Attendo

Symbol: OM:ATT
Market cap: SEK 18.1b

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für Vimian Group
Historische Aktienkurse
Aktueller AktienkursSEK 34.55
52-Wochen-HochSEK 36.20
52-Wochen-TiefSEK 24.18
Beta1.19
1 Monat Veränderung-0.58%
3 Monate Veränderung16.72%
1 Jahr Veränderung14.48%
3 Jahre Veränderung46.90%
5 Jahre Veränderung-62.93%
Veränderung seit IPO-57.29%

Aktuelle Nachrichten und Updates

User avatar
Narrative-Update • Sep 14

VIMIAN: Margin Execution And Lower Risk Assumptions Will Shape Balanced Upside Potential

Analysts now cite slightly higher fair value and margin assumptions, along with a modestly lower discount rate, as reasons for raising their SEK 34.98 price target on Vimian Group to SEK 37.17. What’s in the News for Vimian Group No recent company specific news for Vimian Group has been provided in the available sources as of 14 Sep 2026.
Analyseartikel • Jul 25

Shareholders Can Be Confident That Vimian Group's (STO:VIMIAN) Earnings Are High Quality

Vimian Group AB (publ)'s ( STO:VIMIAN ) strong earnings report was rewarded with a positive stock price move. Our...
User avatar
Narrative-Update • Jul 23

VIMIAN: Rich P/E And Slower Revenue Outlook Will Cap Future Upside

Analysts have raised their price target on Vimian Group to SEK29.08 from SEK26.50, citing updated assumptions that include a lower discount rate, slightly lower revenue growth expectations, a higher projected profit margin and a modestly higher future P/E multiple. What’s in the News for Vimian Group Vimian Group AB held its Annual General Meeting on April 29, 2026.
User avatar
Narrative-Update • Jun 30

VIMIAN: Lower Margin Outlook Will Limit Future Share Price Upside

Analysts have lifted their SEK fair value estimate for Vimian Group from about SEK 24.91 to roughly SEK 26.50. They cited updated assumptions for revenue growth, profit margins and a higher future P/E multiple as key drivers behind the change in price target.

Recent updates

User avatar
Narrative-Update • Sep 14

VIMIAN: Margin Execution And Lower Risk Assumptions Will Shape Balanced Upside Potential

Analysts now cite slightly higher fair value and margin assumptions, along with a modestly lower discount rate, as reasons for raising their SEK 34.98 price target on Vimian Group to SEK 37.17. What’s in the News for Vimian Group No recent company specific news for Vimian Group has been provided in the available sources as of 14 Sep 2026.
Analyseartikel • Jul 25

Shareholders Can Be Confident That Vimian Group's (STO:VIMIAN) Earnings Are High Quality

Vimian Group AB (publ)'s ( STO:VIMIAN ) strong earnings report was rewarded with a positive stock price move. Our...
User avatar
Narrative-Update • Jul 23

VIMIAN: Rich P/E And Slower Revenue Outlook Will Cap Future Upside

Analysts have raised their price target on Vimian Group to SEK29.08 from SEK26.50, citing updated assumptions that include a lower discount rate, slightly lower revenue growth expectations, a higher projected profit margin and a modestly higher future P/E multiple. What’s in the News for Vimian Group Vimian Group AB held its Annual General Meeting on April 29, 2026.
User avatar
Narrative-Update • Jun 30

VIMIAN: Lower Margin Outlook Will Limit Future Share Price Upside

Analysts have lifted their SEK fair value estimate for Vimian Group from about SEK 24.91 to roughly SEK 26.50. They cited updated assumptions for revenue growth, profit margins and a higher future P/E multiple as key drivers behind the change in price target.
User avatar
Narrative-Update • Jun 16

VIMIAN: Lower Discount Rate And New Bylaws Will Support Future Repricing

Analysts have kept their SEK price target for Vimian Group broadly in line with prior estimates, citing slightly adjusted assumptions around the company’s discount rate, revenue growth, profit margin and future P/E as the main drivers of the updated view. What's in the News Vimian Group AB held its Annual General Meeting on April 29, 2026, where shareholders approved the adoption of new Articles of Association.
User avatar
Narrative-Update • Jun 01

VIMIAN: New Bylaws And Improved Assumptions Will Support Future Repricing

Analysts now set their fair value price target for Vimian Group at SEK41.03, a slight trim from SEK41.10. This reflects updated views on discount rates, revenue growth, profit margins, and future P/E assumptions.
User avatar
Narrative-Update • May 06

VIMIAN: Margin Execution And Governance Changes Will Support Future Upside Potential

Analysts now see fair value for Vimian Group at about SEK 35, up from roughly SEK 34, even though the latest Street research includes a reduced price target to SEK 25 from SEK 27. This reflects updated views on revenue growth, margins, the appropriate discount rate and future P/E assumptions.
User avatar
Narrative-Update • Apr 17

VIMIAN: Higher Discount Rate Will Constrain Future Upside Potential

Analysts have trimmed their price target on Vimian Group to SEK 25 from SEK 27, reflecting updated views on discount rates, growth and profitability assumptions. Analyst Commentary Bearish analysts are signaling a more cautious stance on Vimian Group, with the latest move being a reduction in the price target to SEK 25 from SEK 27.
User avatar
Narrative-Update • Apr 03

VIMIAN: Margin Execution And New Bylaws Will Support Future Upside Potential

Analysts have reduced their price target for Vimian Group to SEK 25 from SEK 27, citing updated assumptions on margins and valuation multiples that result in a slightly adjusted fair value model. Analyst Commentary Recent research points to a more cautious stance on Vimian Group, with the updated SEK 25 price target reflecting revised assumptions on margins and valuation multiples rather than a shift in rating.
User avatar
Narrative-Update • Mar 20

VIMIAN: Lower Price Outlook And Execution Risks Will Shape Fair Value Balance

Analysts have trimmed their price target for Vimian Group to SEK 25 from SEK 27, citing updated assumptions on growth, margins and valuation multiples that align the target more closely with recent research views. Analyst Commentary Recent research reflects a cautious tone around Vimian Group, with the latest move being a trim in the price target to SEK 25 from SEK 27.
User avatar
Narrative-Update • Mar 05

VIMIAN: Reduced Price Outlook And Execution Risks Will Shape Fairly Balanced Prospects

Analysts have lowered their price target on Vimian Group to SEK 25 from SEK 27, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. Analyst Commentary Bearish analysts have trimmed their fair value assumptions for Vimian Group, as seen in the reduced price target to SEK 25 from SEK 27.
User avatar
Narrative-Update • Feb 19

VIMIAN: Reset Expectations Will Highlight Execution Under New CEO Appointment

Analysts have trimmed their fair value estimate and price target on Vimian Group to SEK 27 from SEK 37, reflecting updated assumptions around slightly higher growth, a lower profit margin profile and a higher expected P/E multiple, which together point to a more cautious risk return trade off. Analyst Commentary Bullish analysts looking at Vimian Group are focusing less on the headline downgrade and more on what the revised SEK 27 target implies for execution, valuation and growth expectations from here.
Analyseartikel • Feb 16

Vimian Group AB (publ) (STO:VIMIAN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Investors in Vimian Group AB (publ) ( STO:VIMIAN ) had a good week, as its shares rose 5.9% to close at kr27.84...
Analyseartikel • Feb 05

Is Vimian Group (STO:VIMIAN) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
User avatar
Narrative-Update • Feb 05

VIMIAN: Future Leadership Change Will Support Execution Upside Despite Sector Downgrade

Narrative update Analysts have trimmed their price expectations for Vimian Group, with the updated fair value estimate easing from SEK 36.92 to SEK 33.76, as some now see lower future P/E assumptions and have adopted more cautious views similar to the recent SEK 27 price target cut in Street research. Analyst Commentary Recent research updates on Vimian Group have taken a more cautious tone, with the shift to an Underweight rating and a price target of SEK 27, down from SEK 37.
User avatar
Narrative-Update • Jan 22

VIMIAN: Rebased Expectations Will Spotlight Execution Under New Leadership Transition Narrative

Analysts have reduced their fair value estimate for Vimian Group to SEK 41.36 from SEK 41.97, citing slightly higher discount rate assumptions and updated sector views. This follows a recent cut in the Street price target to SEK 27 from SEK 37.
User avatar
Narrative-Update • Jan 08

VIMIAN: Rebased Expectations Will Highlight Execution On M&A-Led Expansion Narrative

Analysts have lowered their fair value estimate for Vimian Group from SEK 51.65 to SEK 41.97, citing more cautious assumptions on revenue growth and valuation multiples in line with recent price target cuts, including the move to SEK 27 from SEK 37 in Barclays' 2026 industry outlook. Analyst Commentary Recent research points to a more cautious stance on Vimian Group, with fair value and price targets recalibrated to reflect updated assumptions on revenue growth and sector valuation.
Analyseartikel • Jan 08

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
User avatar
Narrative-Update • Dec 23

VIMIAN: Downgrade And New CEO Will Shape Medium Term Risk Outlook

Analysts have lowered their price target on Vimian Group from approximately SEK 37 to around SEK 27. This reflects more cautious assumptions on growth, profitability, and valuation multiples in line with a more conservative sector outlook for 2026.
User avatar
Narrative-Update • Dec 09

VIMIAN: Future Leadership Will Drive Cash Flow Execution Upside Despite Sector Downgrade

Analysts have trimmed their price target on Vimian Group by SEK 10 to SEK 27. This reflects slightly higher discount rate assumptions and more conservative long term valuation multiples for the sector.
User avatar
Narrative-Update • Nov 25

VIMIAN: Future Leadership and Expanded Acquisitions Will Drive Market Resilience

Narrative Update on Vimian Group Analysts have lowered Vimian Group's fair value estimate from SEK 38.90 to SEK 36.97. This revision is attributed to reduced revenue growth expectations, a higher discount rate, and a more cautious industry outlook reflected in recent research.
Analyseartikel • Sep 10

Vimian Group AB (publ)'s (STO:VIMIAN) Intrinsic Value Is Potentially 40% Above Its Share Price

Key Insights The projected fair value for Vimian Group is kr43.69 based on 2 Stage Free Cash Flow to Equity Vimian...
User avatar
Narrative-Update • Sep 05

Digital Adoption And Niche Expansion Will Empower Veterinary Healthcare

Ongoing execution challenges in MedTech, anticipated organic growth slowing to 5% in 2025, and required recovery in orthopedics have led analysts to adopt a more cautious outlook and maintain Vimian Group's price target at SEK38.90. Analyst Commentary Ongoing execution challenges in the MedTech segment are impacting overall group momentum.
Analyseartikel • Aug 14

Vimian Group AB (publ) (STO:VIMIAN) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless

OM:VIMIAN 1 Year Share Price vs Fair Value Explore Vimian Group's Fair Values from the Community and select yours...
Analyseartikel • Jun 17

If EPS Growth Is Important To You, Vimian Group (STO:VIMIAN) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analyseartikel • Jun 02

Estimating The Intrinsic Value Of Vimian Group AB (publ) (STO:VIMIAN)

Key Insights Vimian Group's estimated fair value is kr55.41 based on 2 Stage Free Cash Flow to Equity Vimian Group's...
Analyseartikel • May 15

Getting In Cheap On Vimian Group AB (publ) (STO:VIMIAN) Is Unlikely

With a median price-to-sales (or "P/S") ratio of close to 4.6x in the Medical Equipment industry in Sweden, you could...
Analyseartikel • Mar 05

Is Vimian Group (STO:VIMIAN) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analyseartikel • Feb 21

Vimian Group's (STO:VIMIAN) Earnings Are Weaker Than They Seem

Unsurprisingly, Vimian Group AB (publ)'s ( STO:VIMIAN ) stock price was strong on the back of its healthy earnings...
Analyseartikel • Feb 14

A Look At The Fair Value Of Vimian Group AB (publ) (STO:VIMIAN)

Key Insights The projected fair value for Vimian Group is kr54.92 based on 2 Stage Free Cash Flow to Equity Current...
User avatar
Neues Narrative • Feb 09

iM3 Acquisition Will Expand Presence In Veterinary Dental Space

Expansion in Specialty Pharma and strategic focus on cash generation are expected to drive organic growth, enhancing revenue and margins.
Analyseartikel • Dec 16

Returns On Capital Are Showing Encouraging Signs At Vimian Group (STO:VIMIAN)

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
Analyseartikel • Aug 31

Revenues Not Telling The Story For Vimian Group AB (publ) (STO:VIMIAN) After Shares Rise 27%

Vimian Group AB (publ) ( STO:VIMIAN ) shareholders have had their patience rewarded with a 27% share price jump in the...
Analyseartikel • Aug 17

Is Vimian Group (STO:VIMIAN) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Aktionärsrenditen

VIMIANSE Medical EquipmentSE Markt
7D0.6%0.6%-0.7%
1Y14.5%1.4%12.3%

Rendite im Vergleich zur Industrie: VIMIAN übertraf die Branche Swedish Medical Equipment , die im vergangenen Jahr eine Rendite von 1.4 erzielte.

Rendite vs. Markt: VIMIAN übertraf den Markt Swedish, der im vergangenen Jahr eine Rendite von 12.3 erzielte.

Preisvolatilität

Is VIMIAN's price volatile compared to industry and market?
VIMIAN volatility
VIMIAN Average Weekly Movement3.4%
Medical Equipment Industry Average Movement6.3%
Market Average Movement5.2%
10% most volatile stocks in SE Market10.6%
10% least volatile stocks in SE Market2.9%

Stabiler Aktienkurs: VIMIAN hatte in den letzten 3 Monaten im Vergleich zum Swedish -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: VIMIANDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
20201,300Alireza Tajbakhshvimian.com

Die Vimian Group AB (publ) ist weltweit im Bereich der Tiergesundheit tätig. Das Unternehmen ist in den Segmenten Specialty Pharma, MedTech, Diagnostics und Veterinary Services tätig. Unter dem Markennamen Nextmune bietet das Unternehmen eigene Diagnostika, verschreibungspflichtige und nicht verschreibungspflichtige Behandlungen für die präventive Pflege und die Behandlung chronischer Erkrankungen von Haustieren an.

Vimian Group AB (publ)'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Vimian Group im Vergleich zum Marktanteil des Unternehmens?
VIMIAN grundlegende Statistiken
MarktanteilSEK 18.29b
Gewinn(TTM)SEK 415.95m
Umsatz(TTM)SEK 5.10b
44.0x
Kurs-Gewinn-Verhältnis
3.6x
Kurs-Umsatz-Verhältnis

Ist VIMIAN zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
VIMIAN Gewinn- und Verlustrechnung (TTM)
Einnahmen€450.90m
Kosten der Einnahmen€140.60m
Bruttogewinn€310.30m
Sonstige Ausgaben€273.50m
Gewinn€36.80m

Zuletzt gemeldete Gewinne

Jun 30, 2026

Datum des nächsten Gewinnberichts

Oct 22, 2026

Gewinn per Aktie (EPS)0.07
Bruttomarge68.82%
Nettogewinnspanne8.16%
Schulden/Eigenkapital-Verhältnis35.1%

Wie hat sich VIMIAN auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/09/16 15:54
Aktienkurs zum Tagesende2026/09/16 00:00
Gewinne2026/06/30
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
  • SEC-Formular 10-K
  • SEC-Formular 10-Q
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
  • Analysten Research Berichte
  • Blue Matrix
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
  • ICE-Marktdaten
  • SEC-Formular S-1
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
  • SEC-Formular 4
  • SEC-Formular 13D
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
  • SEC-Formular 10-K
  • SEC-Formular DEF 14A
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens
  • SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.

Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Vimian Group AB (publ) wird von 10 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
null nullABG Sundal Collier
Jonathon UnwinBarclays
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB

Triff überall bessere Investmententscheidungen

Zum Herunterladen scannen
App Store öffnenGoogle Play öffnen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Datenquellen anzeigen
Märkte
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideen für Investitionen
  • Unterbewertete Unternehmen
  • Dividendenstarke Unternehmen
  • Insider-Käufe
  • Kernenergie
  • Autonome Fahrzeuge
  • Künstliche Intelligenz
  • Kryptowährung und Blockchain
  • Cybersicherheit
  • Weitere Ideen
Börsengemeinschaften
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Werkzeuge und Funktionen
  • Portfolio-Tracker
  • Aktien-Screener & Alarme
  • Erzählungen & faire Werte
  • Dividenden-Rechner
Nachrichten & Entdeckungen
  • Neueste Bestandsnachrichten
  • Globale Markteinsichten
  • Der Fuchsbau
  • Ideen für Investitionen
  • Community-Erzählungen
  • Was gibt's Neues?
Simply Wall St
  • Pläne & Preisgestaltung
  • Werbung},{
  • Über uns
  • Kontakt
  • Karriere
  • Hilfe-Center
  • Lernen Sie das Investieren in Aktien
  • Partnerprogramm
  • Business & Unternehmen
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Bedingungen und Konditionen
  • Datenschutzbestimmungen
  • KI-Bedingungen
  • Leitfaden für Finanzdienstleistungen